Ciclopirox: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Ciclopirox. Educational only — not medical advice.

Labeled uses

(To understand fully the indication for this product, please read the entire INDICATIONS AND USAGE section of the labeling.) Ciclopirox topical solution, 8% (Nail Lacquer), as a component of a comprehensive management program, is indicated as topical treatment in immunocompetent patients with mild to moderate onychomycosis of fingernails and toenails without lunula involvement, due to Trichophyton rubrum . The comprehensive management program includes removal of the unattached, infected nails as frequently as monthly, by a health care professional who has special competence in the diagnosis and treatment of nail disorders, including minor nail procedures. No studies have been conducted to determine whether ciclopirox might reduce the effectiveness of systemic antifungal agents for onychomycosis. Therefore, the concomitant use of 8% ciclopirox topical solution and systemic antifungal agents for onychomycosis, is not recommended. Ciclopirox topical solution, 8% (Nail Lacquer), should be used only under medical supervision as described above. The effectiveness and safety of ciclopirox topical solution, 8% (Nail Lacquer), in the following populations has not been studied. The clinical …

Source: FDA labeling via NIH DailyMed (set 8ce98020…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.